Analysis of research trends and hotspots of triptolide in recent ten years based on knowledge graph#br#
YUAN Bo1 ZHI Kai2 CUI Weilu1 ZHANG Xieyu1 GE Lin1 CAO Wei3
1.Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China;
2.China Academy of Chinese Medical Sciences, Beijing 100007, China;
3.Wangjing Hospital of China Academy of Chinese Medical Sciences，Beijing 100102, China
Abstract：Objective To explore the development trend and hotspots of triptolide research in recent ten years in China through bibliometric visualization analysis. Methods The literatures related to triptolide included in Chinese National Knowledge Infrastructure from January 2011 to October 2021 were searched, and the included research institutions, authors and keywords were visually analyzed by CiteSpace software. Results The numbers of triptolide-related literature published was stable; the research institutions were mostly Chinese medicine universities and pharmacology-related laboratories, with less inter-institutional cooperation; the authors with the most number of articles were Liu Jianqun, Que Huiqing and Xu Wei, and no core team has been formed in China; the top three keywords in terms of frequency were “apoptosis”, “proliferation”, and “rheumatoid arthritis”, with 12 clusters of keywords and ten emergent words. Conclusion The number of triptolide-related articles issued in the past decade is stable, and the disease types involved in the research are constantly enriched, and preclinical research centered on anti-tumor and oxidative emergency is the hotspot of triptolide research in recent years.
袁博1 智恺2 崔玮璐1 张解玉1 葛琳1 曹炜3. 基于知识图谱分析近10年雷公藤甲素的研究趋势与热点[J]. 中国医药导报, 2022, 19(15): 23-28.
YUAN Bo1 ZHI Kai2 CUI Weilu1 ZHANG Xieyu1 GE Lin1 CAO Wei3. Analysis of research trends and hotspots of triptolide in recent ten years based on knowledge graph#br#. 中国医药导报, 2022, 19(15): 23-28.
[1] Yuan K，Li X，Lu Q，et al. Application and Mechanisms of Triptolide in the Treatment of Inflammatory Diseases—A Review [J]. Front Pharmacol，2019，10：1469.
[2] 陈悦，陈超美，刘则渊，等.CiteSpace知识图谱的方法论功能[J].科学学研究，2015，33（2）：242-253.
[3] 刘文成，谭布珍，方玉婷，等.植物雷公藤主要抗癌抗炎活性成分研究进展[J].中国临床药理学与治疗学，2017， 3（22）：355-360.
[4] 崔进，陈晓，苏佳灿.雷公藤甲素药理作用研究新进展[J].中国中药杂志，2017，42（14）：2655-2658.
[5] 陈鑫，张永萍，徐剑，等.雷公藤甲素的现代研究进展[J].贵州中医药大学学报，2021，43（5）：85-89.
[6] 贺彬，彭向东.治疗支气管哮喘中药研究进展[J].中南药学，2005，3（5）：315-318.
[7] 杨宜承，赵薇，曾常茜，等.雷公藤内酯对海人酸致痫大鼠神经元caspase3和caspase9蛋白表达的影响[J].辽宁中医药大学学报，2013，15（2）：48-50.
[8] 刘帮慧，张瑛.雷公藤甲素对Aβ25-35诱导PC12细胞损伤的保护作用及其机制研究[J].中国现代医学杂志，2017，27（17）：19-34.
[9] 金衔，曾常茜，臧丽丽，等.雷公藤内酯通过下调CⅡTA抑制BV-2小胶质细胞MHCⅡ表达[J].中风与神经疾病杂志，2016，33（8）：729-731.
[10] 张赛圣，杨宝林，程丽霞，等.雷公藤内酯醇对阿尔茨海默病大鼠海马drebrin和cofilin表达的影响[J].中国康复理论与实践，2018，24（1）：23-28.
[11] 任凌燕，朱鸣，朱华艳，等.雷公藤甲素通过调控Toll-样受体（TLR）/核因子κB（NF-κB）信号通路对糖尿病肾病模型小鼠足细胞的作用研究[J].浙江中西医结合杂志，2020，30（3）：191-195，263.
[12] 唐小铁，徐洁，王丽媛，等.雷公藤甲素对糖尿病肾病小鼠肾足细胞自噬及凋亡的影响[J].世界中医药，2019， 14（10）：2623-2626.
[13] 吴薇，刘不悔，万毅刚，等.雷公藤甲素抑制NLRP3炎症小体活化改善高糖诱导的足细胞上皮-间充质转分化[J].中国中药杂志，2019，24（8）：5457-5464.
[14] 石格，吴薇，万毅刚，等.低剂量雷公藤甲素抑制Wnt3α/β-catenin信号通路活性改善高剂量D-葡萄糖诱导的足细胞转分化[J].中国中药杂志，2018，43（1）：139-146.
[15] 王丹妮，于蕊.雷公藤甲素对糖尿病肾病大鼠肾组织PGE2与NF-κB表达的影响[J].解剖科学进展，2017， 23（1）：10-12.
[16] Ma JX， Sun YL，Yu Y，et al. Triptolide enhances the sensitivity of pancreatic cancer PANC-1 cells to gemcitabine by inhibiting TLR4/NF-κB signaling [J]. Am J Transl Res，2019，11（6）：3750-3760.
[17] 高欢，曲晓宇，张月明，等. Erk信号传导通路在雷公藤甲素诱导人乳腺癌MCF-7细胞自噬与凋亡中的影响[J].中国医院药学杂志，2018，38（9）：930-933.
[18] Reno TA，Kim JY，Dan JR. Triptolide Inhibits Lung Cancer Cell Migration，Invasion，and Metastasis [J]. Ann Thorac Surg，2015，100（5）：1817-1825.
[19] Hou ZY，Tong XP，Peng YB，et al. Broad targeting of triptolide to resistance and sensitization for cancer therapy [J]. Biomed Pharmacother，2018，104：771-780.
[20] Ding B，Wahid M A，Wang Z，et al. Triptolide and celastrol loaded silk fibroin nanoparticles show synergistic effect against human pancreatic cancer cells [J]. Nanoscale，2017，9（32）：11739-11753.
[21] Xi Y，Wang W，Wang L，et al. Triptolide induces p53-dependent cardiotoxicity through mitochondrial membrane Permeabilization in cardiomyocytes [J]. Toxicol Appl Pharmacol，2018，355：269-285.
[22] Li J，Liu R，Yang Y，et al. Triptolide-induced in vitro and in vivo cytotoxicity in human breast cancer stem cells and primary breast cancer cells [J]. Oncol Rep，2014，31（5）：2181-2186.
[23] Wang S，Chen X，Ling S，et al. MicroRNA expression，targeting，release dynamics and early-warning biomarkers in acute cardiotoxicity induced by triptolide in rats [J]. Biomed Pharmacother，2019，111：1467-1477.
[24] 王宝娟，付滨，张童燕，等.雷公藤甲素免疫调节机制研究进展[J].河北中医，2015，37（3）：463-465.
[25] Wang X，Nong C，Jiang Z，et al. Effect of triptolide on Th17/Treg cells in spleen [J]. Zhongguo Zhong Yao Za Zhi，2019，44（15）：3330-3334.
京公网安备 11010502046598号